Skip to main content
SpringerLink
Log in

Effects of octreotide on cardiovascular hormones and haemodynamics in conscious dogs

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Octreotide inhibits the secretion of several hormones and exerts vasopressor effects. To clarify the mechanism of atrial natriuretic factor (ANF) secretion and to assess the cardiovascular effects of octreotide in relation to changes in vasoactive peptide secretion, four groups of conscious dogs were studied: group I (n=11) received saline infusion after placebo, group II (n=10), the same infusion after octreotide, group III (n= 10), placebo only and group IV (n =10) octreotide injection only. Saline (10% body wt) was infused over 40 min after subcutaneous injection of placebo or octreotide (1 γ/kg). Saline produced a rise (p<0.001) of plasma ANF from 32.4±4.1 to 59.0±8.5 pM after placebo and from 35.6±5.5 to 77.0±12.6 pM after octreotide. This rise, not significantly different between groups I and II paralleled a 4–5-fold increase (p<0.005) of right and left atrial pressures. With a higher dose of octreotide (4 μg/kg) injected in 4 dogs, plasma ANF increased by 27.5±5 pM. During hypervolemia, plasma endothelial remained unchanged but plasma angiotensin II and epinephrine decreased (p<0.05) approximately by 80% without being affected by octreotide. Octreotide did not influence the basal secretion of ANF, endothelin-1, angiotensin II and catecholamines. However, in basal conditions, octreotide injection resulted in a 9% increase (p<0.005) of left ventricular systolic pressure, unobserved after placebo. Plasma glucose decreased (p<0.005) in groups receiving octreotide. Thus, octreotide does not impair the stretch-mediated release of ANF which implies a release mechanism independent from somatostatin receptors and consequent changes in intracellular c-AMP. Octreotide has also a pressor effect, unrelated to changes in vasoactive peptide production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Grosman I., Simon D. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am. J. Gastroenterol. 85: 1061, 1990.

    PubMed  CAS  Google Scholar 

  2. Reichlin S. Neuroendocrinology. In: Wilson J.D., Foster D.W. (Eds.), Williams Textbook of Endocrinology. W.B. Saunders, Philadelphia, 1992, p. 135.

    Google Scholar 

  3. Patel Y.C. General aspects of the biology and function of somatostatin. In: Weil C., Muller E.E., Thorner M.O., (Eds.), Somatostatin. Springer-Verlag, Berlin Heidelberg, 1992, p. 1.

    Chapter  Google Scholar 

  4. Hou Z.Y., Lin C.I., Chiu T.H., Chiang B.N., Cheng K.K., Ho H.T. Somatostatin effects in isolated human atrial fibres. J. Mol. Cell. Cardiol. 19: 177, 1987.

    Article  PubMed  CAS  Google Scholar 

  5. Lin C.I., Ckeng K.K., Ho L.T. Electropharmacological effects of somatostatin in human atrial fibers. Int. J. Cardiol. 31: 313, 1991.

    Article  PubMed  CAS  Google Scholar 

  6. Greco A.V., Ghirlanda G., Barone C, Bertoli A., Caputo S., Uccioli L., Manna R. Somatostatin in paroxysmal supraventricular and junctional tachycardia. Br. Med. J. 288: 28, 1984.

    Article  CAS  Google Scholar 

  7. Anderson J.V., Donckier J., McKenna W.J., Bloom S.R. The plasma release of atrial natriuretic peptide in man. Clin. Sci. 71: 151, 1986.

    PubMed  CAS  Google Scholar 

  8. Edwards B., Zimmerman R., Schwab T., Heublein D., Burnett J. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ. Res. 62: 191, 1988.

    Article  PubMed  CAS  Google Scholar 

  9. Donckier J., Hanet C., Galanti L., Stoleru L., Van Mechelen H., Robert A., Ketelslegers J.M., Pouleur H. Low-dose endothelin-1 potentiates volume-induced secretion of atrial natriuretic factor. Am. J. Physiol. 263: H939–5, 1992.

    PubMed  CAS  Google Scholar 

  10. Ferri C., De Mattia G., Bellini C., Laurenti O., Bravi C., Baldoncini R., Bonavita M.S., Santucci A., Balsano F. Octreotide, a somatostatin analog, reduces insulin secretion and increases renal Na+ excretion in lean essential hypertensive patients. Am. J. Hypertens. 6: 276, 1993.

    Article  PubMed  CAS  Google Scholar 

  11. Sicuteri F., Panconesi A., Del Bianco P., Franchi G., Anselmi B. Venoplastic activity of somatostatin in vivo in man: naloxone reversible tachyphylaxis. Int. J. Clin. Pharmacol. Res. 4: 253, 1984.

    PubMed  CAS  Google Scholar 

  12. Hoeldtke R.D., Davis K.M., Joseph J., Gonzales R., Panidis J.P., Friedman A.C. Hemodynamic effects of octreotide in patients with autonomic neuropathy. Circulation 84: 168, 1991.

    Article  PubMed  CAS  Google Scholar 

  13. Hoeldtke R.D., O’Dorisio T.M., Boden G. Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995. Lancet 2: 602, 1986.

    Article  PubMed  CAS  Google Scholar 

  14. Eriksson L.S., Wahren J. Intravenous and subcutaneous administration of a long-acting somatostatin analogue: effects on glucose metabolism and splanchnic haemodynamics in healthy subjects. Eur. J. Clin. Invest. 19: 213, 1989.

    Article  PubMed  CAS  Google Scholar 

  15. Stevenson R.W., Steiner K.E., Hendrick G.K., Cherrington A.D. Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs. Am. J. Physiol. 253: 435, 1987.

    Google Scholar 

  16. Donckier J., Hanet C., Berbinschi A., Galanti L., Robert A., Van Mechelen H., Pouleur H., Ketelslegers J.M. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circulation. 84: 2476, 1991.

    Article  PubMed  CAS  Google Scholar 

  17. Sansdrap J., Van Mechelen H., Pouleur H., Charlier A.A. CROPA: a research-oriented program for automatic processing of cardiovascular signals. In: Cox J.R., Hugenholtz P.G. (Eds.), Computers in Cardiology. IEEE Computer Society, Firenze 1981, p. 433.

    Google Scholar 

  18. Donckier J., De Coster P., Buysschaert M., Levecque P., Cauwe F.M., Brichant C.M., Berbinschi A.C., Ketelslegers J.M. Effect of exercise on plasma atrial natriuretic factor and cardiac function in men and women. Eur. J. Clin. Invest. 18: 415, 1988.

    Article  PubMed  CAS  Google Scholar 

  19. Berbinschi A., Ketelslegers J.M. Endothelin in urine. Lancet 2: 46, 1989, (letter).

    Article  PubMed  CAS  Google Scholar 

  20. Koch D.D., Palzin G.L. Effect of sample preparation and liquid chromatography column choice on selectivity and precision of plasma catecholamine determination. J. Chromatogr. 386: 19, 1987.

    Article  PubMed  CAS  Google Scholar 

  21. Lerman A., Hildebrand F.L., Margulies B., O’Murchu B., Perella M.A., Heublein D.M., Schwab T.R., Burnett J.C. Endothelin: a new cardiovascular regulatory peptide. Mayo Clin. Proc. 65: 1441, 1990.

    Article  PubMed  CAS  Google Scholar 

  22. de Bold M.L, de Bold A.J. Effect of manipulations of Ca2+ environment on atrial natriuretic factor release. Am. J. Physiol. 256: H1588, 1989.

    PubMed  Google Scholar 

  23. Kuroski-de Bold M.L., de Bold A.J. Stretch-secretion coupling in atrial cardiocytes. Dissociation between atrial natriuretic factor release and mechanical activity. Hypertension 18(Supl. III) 169, 1991.

    Google Scholar 

  24. Donckier J., De Coster P., Buysschaert M., Van Hoof M., Cauwe F., Robert A., Berbinschi A., Ketelslegers J.M. Effect of ß-adrenergic blockade on plasma atrial natriuretic factor and cardiac volumes during exercise in normal men. Am. J. Cardiol. 63: 1000, 1989.

    Article  PubMed  CAS  Google Scholar 

  25. Wong N.L.M., Wong E.F., Au G.H., Hu D.C. Effect of α- and ß-adrenergic Stimulation on atrial natriuretic peptide release in vitro. Am. J. Physiol. 255: E260, 1988.

    PubMed  CAS  Google Scholar 

  26. Sonnenberg H., Veress A.T. Cellular mechanism of release of atrial natriuretic factor. Biochem. Biophys. Res. Commun. 124: 443, 1984.

    Article  PubMed  CAS  Google Scholar 

  27. Gilbert E.M., Eiswirth C.C., Mealey P.C., Larrabee P., Herrick C.M., Bristow M.R. ß-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin. Circulation 79: 344, 1989.

    Article  PubMed  CAS  Google Scholar 

  28. Lurie K.G., Bristow M.R., Reitz B.A. Increased ß-adrenergic receptor density in an experimental model of cardiac transplantation. J. Thorac. Cardiovasc. Surg. 86: 19, 1983.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology and Internal Medicine, University Hospital of Mont-Godinne, B-5530, Yvoir, Belgium

    J. Donckier M.D., Ph.D. & L. Galanti

  2. Department of Physiology, University of Louvain, Brussels, Belgium

    L. Stoleru, H. Van Mechelen & A. A. Charlier

  3. Unit of Diabetology and Nutrition, University of Louvain, Brussels, Belgium

    Ph. Selvais & J. M. Ketelslegers

Authors
  1. J. Donckier M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Stoleru
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ph. Selvais
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Galanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Van Mechelen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. M. Ketelslegers
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. A. Charlier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Donckier, J., Stoleru, L., Selvais, P. et al. Effects of octreotide on cardiovascular hormones and haemodynamics in conscious dogs. J Endocrinol Invest 19, 106–113 (1996). https://doi.org/10.1007/BF03349845

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349845

Key-words

Search

Navigation